Search results for "Modafinil"

showing 5 items of 5 documents

Methylphenidate, modafinil, and caffeine for cognitive enhancement in chess: A double-blind, randomised controlled trial.

2017

Stimulants and caffeine have been proposed for cognitive enhancement by healthy subjects. This study investigated whether performance in chess - a competitive mind game requiring highly complex cognitive skills - can be enhanced by methylphenidate, modafinil or caffeine. In a phase IV, randomized, double-blind, placebo-controlled trial, 39 male chess players received 2×200mg modafinil, 2×20mg methylphenidate, and 2×200mg caffeine or placebo in a 4×4 crossover design. They played twenty 15-minute games during two sessions against a chess program (Fritz 12; adapted to players' strength) and completed several neuropsychological tests. Marked substance effects were observed since all three subs…

AdultMaleElementary cognitive taskmedicine.medical_specialtyModafinilAudiologyNeuropsychological TestsPlacebolaw.inventionDevelopmental psychology03 medical and health sciences0302 clinical medicineCognitionRandomized controlled trialDouble-Blind MethodlawCaffeinemedicineHumansPharmacology (medical)Benzhydryl CompoundsBiological PsychiatryRetrospective StudiesPharmacologyAnalysis of VarianceMethylphenidateModafinilNeuropsychologyCognitionWakefulness-Promoting AgentsMiddle AgedCrossover study030227 psychiatryPsychiatry and Mental healthCross-Sectional StudiesNeurologyMethylphenidateCentral Nervous System StimulantsFemaleNeurology (clinical)Psychologyhuman activities030217 neurology & neurosurgerymedicine.drugEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
researchProduct

Pharmacological Neuroenhancement: Substances and Epidemiology

2013

Pharmacological neuroenhancement (PN) refers to the general use of psychoactive substances with the purpose of cognitive enhancement (e.g. enhancement of vigilance, concentration, memory or mood) by healthy subjects. Substances for PN include Over-the-Counter- (OTC-) substances such as coffee, caffeinated drinks/energy drinks, caffeine tablets and Ginkgo biloba as well as prescription drugs and illicit drugs (e.g. (psycho-) stimulants). “Brain doping” refers to the illicit use of a subcategory of these substances. On the one hand, this subcategory includes prescription drugs for the treatment of attention deficit/hyperactivity disorder (ADHD), sleep disorders, Alzheimer’s disease and depres…

Methylphenidatebusiness.industryEcstasyModafinilMemantineNeuroenhancementPharmacologychemistry.chemical_compoundMoodchemistrymental disordersmedicineMedical prescriptionCaffeinebusinessmedicine.drug
researchProduct

Smart drugs: de la terapia al transhumanismo

2018

ABSTRACT Enhancing human cognitive capacities is one of the central axes of transhumanist proposals. In recent decades, halfway between the actual and the possible, another way of approaching human mind enhancement has appeared: smart drugs —also known as cognitive enhancers or nootropics— psychopharmaceuticals that promise an improvement in cognition, memory, intelligence, attention, concentration... These drugs are currently used in the therapeutic field, but many think that the barriers between therapy and human enhancement are fading away. This paper presents three smart drugs —methylphenidate, modafinil and pyracetam— and reflects on the limits between therapy and enhancement, placing …

ModafiniloComputer Networks and CommunicationsPsychologyHumanitiesComputer Science ApplicationsInformation SystemsTranshumanismTECHNO REVIEW. International Technology, Science and Society Review /Revista Internacional de Tecnología, Ciencia y Sociedad
researchProduct

Use of Caffeine for Cognitive Enhancement

2015

Abstract Pharmacological cognitive enhancement (CE) refers to the use of divergent psychoactive substances with the purpose of enhancing one's own cognition (e.g., increasing vigilance, concentration, memory). The group of substances for CE includes divergent over-the-counter drugs. Caffeine-containing products such as coffee, caffeinated drinks, and caffeine tablets are integral part of this group of substances. Furthermore, prescription drugs as well as illicit drugs belong to this group of CE substances (e.g., [psycho-]stimulants, modafinil). The use of caffeine in normal healthy subjects has very limited procognitive effects. However, there are few procognitive effects in healthy but sl…

business.industrymedia_common.quotation_subjectModafinilHealthy subjectsLifetime prevalenceNeuroenhancementCognitionPharmacologychemistry.chemical_compoundchemistrymedicinebusinessCaffeineVigilance (psychology)media_commonmedicine.drug
researchProduct

Medications between psychiatric and addictive disorders

2016

International audience; Introduction : Many epidemiological studies have revealed a frequent co-occurrence of psychiatric and substance use disorders. The term used in the literature to refer to this co-occurrence is dual diagnosis. The high prevalence of dual diagnosis has led physicians to observe the effects of medication prescribed to treat psychiatric disorders on the co-occurring substance use disorder and vice versa. The concept of medications between psychiatric and addictive disorders stems from these clinical observations, alongside which, however, it has developed from the observation that both psychiatric and substance use disorders share common neurobiological pathways and trig…

medicine.medical_specialtyPsychotherapistSubstance-Related Disordersmedia_common.quotation_subject[SDV]Life Sciences [q-bio][ SDV.MHEP.PSM ] Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthAddictionModafinilMirtazapine[ SCCO.PSYC ] Cognitive science/Psychology03 medical and health sciences0302 clinical medicineCognitionEpidemiology of child psychiatric disordersmedicineAnimalsHumansDual diagnosisMedical prescriptionPsychiatryClozapineBiological PsychiatryDepression (differential diagnoses)ComputingMilieux_MISCELLANEOUSmedia_commonPharmacologyPsychotropic DrugsDepressionAddictionmedicine.disease3. Good health030227 psychiatrySubstance abuseClinical researchSchizophreniaDiagnosis Dual (Psychiatry)[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental health[SCCO.PSYC]Cognitive science/PsychologySchizophreniaDual diagnosisPsychologyPsychiatric disorders030217 neurology & neurosurgery
researchProduct